Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

David A. Fiellin,Linda Weiss,Michael Botsko,James E. Egan,Frederick L. Altice,Lauri Bazerman,Amina Chaudhry,Chinazo O. Cunningham,Marc N. Gourevitch,Paula J. Lum,Lynn E. Sullivan,Richard S. Schottenfeld,Patrick G. O’Connor

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

2011

David A. Fiellin
Linda Weiss
Michael Botsko
James E. Egan
Frederick L. Altice
Lauri Bazerman
Amina Chaudhry
Chinazo O. Cunningham
Marc N. Gourevitch
Paula J. Lum
Lynn E. Sullivan
Richard S. Schottenfeld
Patrick G. O’Connor

Background:Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment.Methods:We conducted a prospective study in HIV-infected opioid-dependent patients to investigate the impact of buprenorphine/naloxone treatment on drug use. Self-report and chart review assessments were

Keywords:

Prospective cohort study
Opiate Substitution Treatment
Drug
Buprenorphine
Odds ratio
Opioid
Medicine
Lentivirus
Methadone
Anesthesia
Population
HIV/AIDS
Internal medicine
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations